Pharmaceutical giant Novo Nordisk announced Monday it is suing telemedicine platform Hims & Hers for allegedly “deceiving patients and putting their health at risk” by selling compounded versions of its blockbuster GLP-1 medication semaglutide. Novo Nordisk alleges in its lawsuit that Hims & Hers has infringed on its patent by selling compounded Ozempic and Wegovy…
NYC Airbnb Crackdown: How Homeowners Are Adapting in 2026
New York City’s Airbnb crackdown has reduced short-term rental listings by more than 90%. Discover how homeowners are adapting to stricter rental rules and rising property costs.



0 Comments